Acute Coronary Syndromes
RSSArticles
-
Short course treatment for latent TB
-
All antidepressants are created equal
-
Adverse drug events in the elderly
-
Warfarin testing every 12 weeks?
-
Rivaroxaban for atrial fibrillation patients
Rivaroxaban (Xarelto), Janssen Pharmaceutical's once-a-day oral Xa inhibitor, has been approved for reducing the risk of stroke in patients with atrial fibrillation. -
FDA actions
-
Is it time to retire niacin?
-
News Briefs: Survey: Physicians are worried about the impact of health reform on ED volume
-
Clinical pharmacists with EM training slash medication errors, help to optimize therapies in the ED
Despite continuing pressure to streamline operations, a small but growing number of EDs are adding clinical pharmacists with specialized training in emergency medicine to their ranks. -
Boost efficiency, patient satisfaction with staff-driven improvements
When Robert Wood Johnson University Hospital in Hamilton, NJ, redesigned the ED to handle increasing patient volume back in 2001, its guarantee to see and treat patients quickly kind of "went by the wayside," explains Lisa Breza, RN, BSN, the hospital's chief nursing officer.